1
|
Deng Y, Li H, Wang M, Li N, Tian T, Wu Y,
Xu P, Yang S, Zhai Z, Zhou L, et al: Global burden of thyroid
cancer from 1990 to 2017. JAMA Netw Open. 3:e2087592020. View Article : Google Scholar : PubMed/NCBI
|
2
|
Sun X, Xu X, Wang Y, Hou B, Luo T, Meng D,
Wang S and Ning F: Incidence and mortality rates of lung cancer in
Qingdao, China (2013–2017). Asia Pac J Clin Oncol. 18:e73–e78.
2022. View Article : Google Scholar : PubMed/NCBI
|
3
|
Czaja JM and McCaffrey TV: The surgical
management of laryngotracheal invasion by well-differentiated
papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg.
123:484–490. 1997. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lin S, Huang H, Liu X, Li Q, Yang A, Zhang
Q, Guo Z and Chen Y: Treatments for complications of tracheal
sleeve resection for papillary thyroid carcinoma with tracheal
invasion. Eur J Surg Oncol. 40:176–181. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Detterbeck FC, Chansky K, Groome P,
Bolejack V, Crowley J, Shemanski L, Kennedy C, Krasnik M, Peake M,
Rami-Porta R, et al: The IASLC lung cancer staging project:
Methodology and Validation used in the development of proposals for
revision of the stage classification of NSCLC in the Forthcoming
(Eighth) Edition of the TNM Classification of Lung Cancer. J Thorac
Oncol. 11:1433–1446. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Carhill AA, Litofsky DR, Ross DS, Jonklaas
J, Cooper DS, Brierley JD, Ladenson PW, Ain KB, Fein HG, Haugen BR,
et al: Long-Term outcomes following therapy in differentiated
thyroid carcinoma: NTCTCS Registry Analysis 1987–2012. J Clin
Endocrinol Metab. 100:3270–3279. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Nishida T, Nakao K and Hamaji M:
Differentiated thyroid carcinoma with airway invasion: Indication
for tracheal resection based on the extent of cancer invasion. J
Thorac Cardiovasc Surg. 114:84–92. 1997. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wada N, Nakayama H, Masudo Y, Suganuma N
and Rino Y: Clinical outcome of different modes of resection in
papillary thyroid carcinomas with laryngotracheal invasion.
Langenbecks Arch Surg. 391:545–549. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Moritani S: Surgical management of
cricotracheal invasion by papillary thyroid carcinoma. Ann Surg
Oncol. 22:4002–4007. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Shadmehr MB, Farzanegan R, Zangi M,
Mohammadzadeh A, Sheikhy K, Pejhan S, Daneshvar A and
Abbasidezfouli A: Thyroid cancers with laryngotracheal invasion.
Eur J Cardiothorac Surg. 41:635–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gaissert HA, Honings J, Grillo HC, Donahue
DM, Wain JC, Wright CD and Mathisen DJ: Segmental laryngotracheal
and tracheal resection for invasive thyroid carcinoma. Ann Thorac
Surg. 83:1952–1959. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang J, Fu C, Cui K and Ma X: Papillary
thyroid carcinoma with tracheal invasion: A case report. Medicine
(Baltimore). 98:e170332019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ebihara M, Kishimoto S, Hayashi R,
Miyazaki M, Shinozaki T, Daiko H, Saikawa M, Sakuraba M and
Miyamoto S: Window resection of the trachea and secondary
reconstruction for invasion by differentiated thyroid carcinoma.
Auris Nasus Larynx. 38:271–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Honings J, Stephen AE, Marres HA and
Gaissert HA: The management of thyroid carcinoma invading the
larynx or trachea. Laryngoscope. 120:682–689. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yang Z, Flores J, Katz S, Nathan CA and
Mehta V: Comparison of survival outcomes following postsurgical
radioactive iodine versus external beam radiation in stage IV
differentiated thyroid carcinoma. Thyroid. 27:944–952. 2017.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Kris MG, Gaspar LE, Chaft JE, Kennedy EB,
Azzoli CG, Ellis PM, Lin SH, Pass HI, Seth R, Shepherd FA, et al:
Adjuvant systemic therapy and adjuvant radiation therapy for stage
I to IIIA completely resected non-small-cell lung cancers: American
Society of clinical oncology/cancer care ontario clinical practice
guideline update. J Clin Oncol. 35:2960–2974. 2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Masters GA, Temin S, Azzoli CG, Giaccone
G, Baker S Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller
JH, et al: Systemic therapy for stage IV nonsmall-cell lung cancer:
American society of clinical oncology clinical practice guideline
update. J Clin Oncol. 33:3488–3515. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Garon EB, Rizvi NA, Hui R, Leighl N,
Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L,
et al: Pembrolizumab for the treatment of non-small-cell lung
cancer. N Engl J Med. 372:2018–2028. 2015. View Article : Google Scholar : PubMed/NCBI
|